View Item 

Show simple item record

Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative
dc.contributor.authorCarbone, Laura Den_US
dc.contributor.authorHovey, Kathleen Men_US
dc.contributor.authorAndrews, Christopher Aen_US
dc.contributor.authorThomas, Fridtjofen_US
dc.contributor.authorSorensen, Mathew Den_US
dc.contributor.authorCrandall, Carolyn Jen_US
dc.contributor.authorWatts, Nelson Ben_US
dc.contributor.authorBethel, Moniqueen_US
dc.contributor.authorJohnson, Karen Cen_US
dc.date.accessioned2015-11-12T21:03:30Z
dc.date.available2017-01-03T16:21:16Zen
dc.date.issued2015-11en_US
dc.identifier.citationCarbone, Laura D; Hovey, Kathleen M; Andrews, Christopher A; Thomas, Fridtjof; Sorensen, Mathew D; Crandall, Carolyn J; Watts, Nelson B; Bethel, Monique; Johnson, Karen C (2015). "Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative." Journal of Bone and Mineral Research 30(11): 2096-2102.en_US
dc.identifier.issn0884-0431en_US
dc.identifier.issn1523-4681en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/115895
dc.description.abstractKidney and bladder stones (urinary tract stones) and osteoporosis are prevalent, serious conditions for postmenopausal women. Men with kidney stones are at increased risk of osteoporosis; however, the relationship of urinary tract stones to osteoporosis in postmenopausal women has not been established. The purpose of this study was to determine whether urinary tract stones are an independent risk factor for changes in bone mineral density (BMD) and incident fractures in women in the Women's Health Initiative (WHI). Data were obtained from 150,689 women in the Observational Study and Clinical Trials of the WHI with information on urinary tract stones status: 9856 of these women reported urinary tract stones at baseline and/or incident urinary tract stones during follow‐up. Cox regression models were used to determine the association of urinary tract stones with incident fractures and linear mixed models were used to investigate the relationship of urinary tract stones with changes in BMD that occurred during WHI. Follow‐up was over an average of 8 years. Models were adjusted for demographic and clinical factors, medication use, and dietary histories. In unadjusted models there was a significant association of urinary tract stones with incident total fractures (HR 1.10; 95% CI, 1.04 to 1.17). However, in covariate adjusted analyses, urinary tract stones were not significantly related to changes in BMD at any skeletal site or to incident fractures. In conclusion, urinary tract stones in postmenopausal women are not an independent risk factor for osteoporosis. © 2015 American Society for Bone and Mineral Research.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMENOPAUSEen_US
dc.subject.otherDXAen_US
dc.subject.otherDXAen_US
dc.subject.otherOSTEOPOROSISen_US
dc.subject.otherGENERAL POPULATION STUDIESen_US
dc.subject.otherAGINGen_US
dc.titleUrinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiativeen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialitiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115895/1/jbmr2553.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/115895/2/jbmr2553_am.pdf
dc.identifier.doi10.1002/jbmr.2553en_US
dc.identifier.sourceJournal of Bone and Mineral Researchen_US
dc.identifier.citedreferenceMcTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA. 2003; 290 ( 10 ): 1331 – 6.en_US
dc.identifier.citedreferenceWeaver CM. Potassium and health. Adv Nutr. 2013; 4 ( 3 ): 368S – 77S.en_US
dc.identifier.citedreferenceTucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999; 69 ( 4 ): 727 – 36.en_US
dc.identifier.citedreferenceCipriani C, Biamonte F, Costa AG, et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab. 2015 Apr; 100 ( 4 ): 1309 – 15.en_US
dc.identifier.citedreferenceZhou W, Langsetmo L, Berger C, et al. Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population‐based study: the Canadian Multicentre Osteoporosis Study (CaMos). J Musculoskelet Neuronal Interact. 2013; 13 ( 4 ): 470 – 9.en_US
dc.identifier.citedreferenceCauley JA. The Women's Health Initiative: hormone therapy and calcium/vitamin D supplementation trials. Curr Osteoporos Rep. 2013; 11 ( 3 ): 171 – 8.en_US
dc.identifier.citedreferenceJackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354 ( 7 ): 669 – 83.en_US
dc.identifier.citedreferenceCandelas G, Martinez‐Lopez JA, Rosario MP, Carmona L, Loza E. Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review. Clin Exp Rheumatol. 2012; 30 ( 6 ): 954 – 61.en_US
dc.identifier.citedreferenceFavus MJ. The risk of kidney stone formation: the form of calcium matters. Am J Clin Nutr. 2011; 94 ( 1 ): 5 – 6.en_US
dc.identifier.citedreferenceChen Z, Kooperberg C, Pettinger MB, et al. Validity of self‐report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause. 2004; 11 ( 3 ): 264 – 74.en_US
dc.identifier.citedreferenceJackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium‐vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13 ( 9 Suppl ): S98 – 106.en_US
dc.identifier.citedreferencePatterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs‐Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999; 9 ( 3 ): 178 – 87.en_US
dc.identifier.citedreferenceTrumbo P, Schlicker S, Yates AA, Poos M, Food; Food and Nutrition Board of the Institute of Medicine, The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102 ( 11 ): 1621 – 30.en_US
dc.identifier.citedreferenceAinsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011; 43 ( 8 ): 1575 – 81.en_US
dc.identifier.citedreferenceHall WD, Pettinger M, Oberman A, et al. Risk factors for kidney stones in older women in the southern United States. Am J Med Sci. 2001; 322 ( 1 ): 12 – 8.en_US
dc.identifier.citedreferenceSorensen MD, Hsi RS, Chi T, et al. Women's Health Initiative Writing Group. Dietary intake of fiber, fruit, and vegetables decrease the risk of incident kidney stones in women: a Women's Health Initiative (WHI) Report. J Urol. 2014 Dec; 192 ( 6 ): 1694 – 9.en_US
dc.identifier.citedreferenceDenburg MR, Leonard MB, Haynes K, et al. Risk of fracture in urolithiasis: a population‐based cohort study using the health improvement network. Clin J Am Soc Nephrol. 2014; 9 ( 12 ): 2133 – 40.en_US
dc.identifier.citedreferenceDaudon M. [Epidemiology of nephrolithiasis in France]. Ann Urol (Paris). 2005; 39 ( 6 ): 209 – 31. French.en_US
dc.identifier.citedreferenceTracy CR, Best S, Bagrodia A, et al. Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol. 2014; 192 ( 1 ): 137 – 41.en_US
dc.identifier.citedreferenceSorensen MD, Kahn AJ, Reiner AP, et al. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol. 2012; 187 ( 5 ): 1645 – 9.en_US
dc.identifier.citedreferenceCurhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993; 328 ( 12 ): 833 – 8.en_US
dc.identifier.citedreferenceMarangella M, Vitale C, Bagnis C, Petrarulo M, Tricerri A. Use of drugs for nephrolithiasis. Clin Cases Miner Bone Metab. 2008; 5 ( 2 ): 131 – 4.en_US
dc.identifier.citedreferenceLalau JD, Achard JM, Bataille P, et al. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium‐protein intake and vitamin D metabolism]. Ann Med Interne (Paris). 1992; 143 ( 5 ): 293 – 8. French.en_US
dc.identifier.citedreferenceSchwartz BF, Stoller ML. The vesical calculus. Urol Clin North Am. 2000; 27 ( 2 ): 333 – 46.en_US
dc.identifier.citedreferenceOrchard TS, Larson JC, Alghothani N, et al. Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study. Am J Clin Nutr. 2014; 99 ( 4 ): 926 – 33.en_US
dc.identifier.citedreferenceVigen R, Weideman RA, Reilly RF. Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence‐based fashion? Int Urol Nephrol. 2011; 43 ( 3 ): 813 – 9.en_US
dc.identifier.citedreferenceBolland MJ, Ames RW, Horne AM, Orr‐Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007; 18 ( 4 ): 479 – 86.en_US
dc.identifier.citedreferenceFeskanich D, Willett WC, Stampfer MJ, Colditz GA. A prospective study of thiazide use and fractures in women. Osteoporos Int. 1997; 7 ( 1 ): 79 – 84.en_US
dc.identifier.citedreferenceAnderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003; 13 ( 9 Suppl ): S5 – 17.en_US
dc.identifier.citedreferenceBrauer CA, Coca‐Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009; 302 ( 14 ): 1573 – 9.en_US
dc.identifier.citedreferenceScales CD Jr, Smith AC, Hanley JM, Saigal CS. Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012; 62 ( 1 ): 160 – 5.en_US
dc.identifier.citedreferenceJaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res. 1994; 9 ( 10 ): 1525 – 32.en_US
dc.identifier.citedreferenceLauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001; 16 ( 10 ): 1893 – 8.en_US
dc.identifier.citedreferenceBleicher K, Cumming RG, Naganathan V, et al. Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study. Osteoporos Int. 2011; 22 ( 9 ): 2421 – 37.en_US
dc.identifier.citedreferenceCauley JA, Fullman RL, Stone KL, et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005; 16 ( 12 ): 1525 – 37.en_US
dc.identifier.citedreferenceCauley JA, Blackwell T, Zmuda JM, et al. Correlates of trabecular and cortical volumetric bone mineral density at the femoral neck and lumbar spine: the osteoporotic fractures in men study (MrOS). J Bone Miner Res. 2010; 25 ( 9 ): 1958 – 71.en_US
dc.identifier.citedreferenceSowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B. Prevalence of renal stones in a population‐based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol. 1998; 147 ( 10 ): 914 – 20.en_US
dc.identifier.citedreferenceMelton LJ 3rd, Crowson CS, Khosla S, Wilson DM, O'Fallon WM. Fracture risk among patients with urolithiasis: a population‐based cohort study. Kidney Int. 1998; 53 ( 2 ): 459 – 64.en_US
dc.identifier.citedreferencePietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res. 1992; 7 ( 12 ): 1383 – 8.en_US
dc.identifier.citedreferenceAsplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003; 63 ( 2 ): 662 – 9.en_US
dc.identifier.citedreferenceCaudarella R, Vescini F, Buffa A, et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol. 2003; 16 ( 2 ): 260 – 6.en_US
dc.identifier.citedreferenceAlhava EM, Juuti M, Karjalainen P. Bone mineral density in patients with urolithiasis. A preliminary report. Scand J Urol Nephrol. 1976; 10 ( 2 ): 154 – 6.en_US
dc.identifier.citedreferenceKeller JJ, Lin CC, Kang JH, Lin HC. Association between osteoporosis and urinary calculus: evidence from a population‐based study. Osteoporos Int. 2013; 24 ( 2 ): 651 – 7.en_US
dc.identifier.citedreferenceGiannini S, Nobile M, Dalle Carbonare L, et al. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol. 2003; 149 ( 3 ): 209 – 13.en_US
dc.identifier.citedreferenceLiern M, Bohorquez M, Vallejo G. Treatment of idiopathic hypercalciuria and its impact on associated diseases. Arch Argent Pediatr. 2013; 111 ( 2 ): 110 – 4.en_US
dc.identifier.citedreferenceAruga S, Honma Y. [Renal calcium excretion and urolithiasis]. Clin Calcium. 2011; 21 ( 10 ): 1465 – 72. Japanese.en_US
dc.identifier.citedreferenceCaudarella R, Vescini F, Rizzoli E, Francucci CM. Salt intake, hypertension, and osteoporosis. J Endocrinol Invest. 2009; 32 ( 4 Suppl ): 15 – 20.en_US
dc.identifier.citedreferenceTeucher B, Dainty JR, Spinks CA, et al. Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res. 2008; 23 ( 9 ): 1477 – 85.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jbmr2553.pdf
Size:
159.5KB
Format:
PDF
View/Open
Name:
jbmr2553_am.pdf
Size:
186.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.